C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/18 (2006.01) C12N 15/51 (2006.01) C12Q 1/37 (2006.01) G01N 33/50 (2006.01) G06F 17/50 (2006.01)
Patent
CA 2551074
The present invention is directed to mutants of HCV NS3/4A protease. More particularly, the present invention identifies mutant of HCV NS3/4A protease that are resistant to drug treatment.
L'invention concerne des mutants de la protéase HCV NS3/4A. L'invention concerne, en particulier, l'invention permet d'identifier des mutants des protéases HCV NS3/4A qui sont résistants au traitement médicamenteux.
Lin Chao
Lin Kai
Goudreau Gage Dubuc
Vertex Pharmaceuticals Incorporated
LandOfFree
Hcv ns3-ns4a protease resistance mutants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hcv ns3-ns4a protease resistance mutants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hcv ns3-ns4a protease resistance mutants will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1436098